| Jul 25 |
Dren Bio and Novartis link on bispecific antibodies for cancer
|
| Jul 24 |
Novartis to collaborate with Dren Bio on bispecific antibody therapies
|
| Jul 24 |
Is a Beat in the Cards for Incyte (INCY) in Q2 Earnings?
|
| Jul 24 |
Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
|
| Jul 23 |
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
|
| Jul 20 |
Novartis: Another Beat, Another Raise
|
| Jul 19 |
Why Novartis Deserves Your Attention After Q2 2024 Results
|
| Jul 19 |
Ionis (IONS) Completes Enrolment for Rare Disease Drug Study
|
| Jul 19 |
Pharma Stock Roundup: JNJ, NVS Q2 Earnings, RHHBY's Positive Obesity Pill Data
|
| Jul 19 |
Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug
|
